MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)

Clinical trial NCT05494736 · COMPLETED

Trial details

NCT number: NCT05494736
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2022-11-17
Primary completion: 2024-01-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.